Literature DB >> 2191018

Plasma catecholamine concentration during sedation in ventilated patients requiring intensive therapy.

K L Kong1, S M Willatts, C Prys-Roberts, J T Harvey, S Gorman.   

Abstract

The effects of isoflurane and midazolam sedation on the catecholamine responses of ventilated patients were studied over a 24-h period. Sixty ventilated patients admitted to our intensive therapy unit were allocated randomly to receive either isoflurane or midazolam sedation. Arterial blood samples for plasma catecholamine concentrations were taken at baseline, 6 h after starting sedation and at the end of the study period. Patients sedated with isoflurane showed a progressive reduction in both adrenaline and noradrenaline concentrations during the period of sedation which reached statistical significance for adrenaline at 6 h (p less than 0.02) and at the end of the study (p less than 0.001). Patients sedated with midazolam showed no significant changes of adrenaline or noradrenaline concentrations. Overall, a more satisfactory degree of sedation was achieved with isoflurane.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2191018     DOI: 10.1007/bf01724797

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  15 in total

1.  Treatment of sympathetic overactivity in tetanus.

Authors:  C Prys-Roberts; J L Corbett; J H Kerr; A C Smith; J M Spalding
Journal:  Lancet       Date:  1969-03-15       Impact factor: 79.321

2.  Involvement of the sympathetic nervous system in tetanus. Studies on 82 cases.

Authors:  J H Kerr; J L Corbett; C Prys-Roberts; A C Smith; J M Spalding
Journal:  Lancet       Date:  1968-08-03       Impact factor: 79.321

3.  Prognostic value of the stress response following stroke.

Authors:  J H Feibel; P M Hardy; R G Campbell; M N Goldstein; R J Joynt
Journal:  JAMA       Date:  1977-09-26       Impact factor: 56.272

4.  Assay of plasma catecholamines by liquid chromatography with electrochemical detection.

Authors:  R C Causon; M E Carruthers; R Rodnight
Journal:  Anal Biochem       Date:  1981-09-01       Impact factor: 3.365

5.  Pulmonary extraction of catecholamines in critically ill patients.

Authors:  W J Russell; D B Frewin; J R Jonsson
Journal:  Anaesth Intensive Care       Date:  1982-11       Impact factor: 1.669

6.  Reduction of stress/catecholamine-induced cardiac necrosis by beta 1-selective blockade.

Authors:  J M Cruickshank; G Neil-Dwyer; J P Degaute; Y Hayes; T Kuurne; J Kytta; J L Vincent; M E Carruthers; S Patel
Journal:  Lancet       Date:  1987-09-12       Impact factor: 79.321

7.  Plasma concentrations of catecholamines following adrenaline infiltration during gynaecological surgery.

Authors:  J M Low; J T Harvey; G M Cooper; W J Prendiville
Journal:  Br J Anaesth       Date:  1984-08       Impact factor: 9.166

8.  Postoperative analgesia with controlled-release morphine sulphate: comparison with intramuscular morphine.

Authors:  D Fell; A Chmielewski; G Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-10

9.  Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.

Authors:  W E Clutter; D M Bier; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

10.  Changes in noradrenaline plasma levels and behavioural responses induced by benzodiazepine agonists with the benzodiazepine antagonist Ro 15-1788.

Authors:  T Duka; M Ackenheil; J Noderer; A Doenicke; R Dorow
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

View more
  4 in total

Review 1.  Critical care pharmacotherapy. A review.

Authors:  M Tryba; P J Kulka
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

2.  Effects of medetomidine and midazolam alone or in combination on the metabolic and neurohormonal responses in healthy cats.

Authors:  Teppei Kanda; Yoshiaki Hikasa
Journal:  Can J Vet Res       Date:  2008-07       Impact factor: 1.310

Review 3.  Sleep in the intensive care unit.

Authors:  Sairam Parthasarathy; Martin J Tobin
Journal:  Intensive Care Med       Date:  2003-10-16       Impact factor: 17.440

4.  Isoflurane for prolonged sedation in the intensive care unit; efficacy and safety.

Authors:  E M Spencer; S M Willatts
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.